Evidence map›Paper›PMID 39852315›Full record

ReviewJournal of imaging2024

The Neural Frontier of Future Medical Imaging: A Review of Deep Learning for Brain Tumor Detection.

Tarek Berghout

Abstract readReview
In one paragraph

Review in Journal of imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. [Application of hybrid attention guided dual-path residual learning in magnetic resonance imaging diagnosis].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tarek BerghoutLaboratory of Automation and Manufacturing Engineering, Department of Industrial Engineering, Batna 2 University, Batna 05000, Algeria.ORCID 0000-0003-4877-4200

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumor detection is crucial in medical research due to high mortality rates and treatment challenges. Early and accurate diagnosis is vital for improving patient outcomes, however, traditional methods, such as manual Magnetic Resonance Imaging (MRI) analysis, are often time-consuming and error-prone. The rise of deep learning has led to advanced models for automated brain tumor feature extraction, segmentation, and classification. Despite these advancements, comprehensive reviews synthesizing recent findings remain scarce. By analyzing over 100 research papers over past half-decade (2019-2024), this review fills that gap, exploring the latest methods and paradigms, summarizing key concepts, challenges, datasets, and offering insights into future directions for brain tumor detection using deep learning. This review also incorporates an analysis of previous reviews and targets three main aspects: feature extraction, segmentation, and classification. The results revealed that research primarily focuses on Convolutional Neural Networks (CNNs) and their variants, with a strong emphasis on transfer learning using pre-trained models. Other methods, such as Generative Adversarial Networks (GANs) and Autoencoders, are used for feature extraction, while Recurrent Neural Networks (RNNs) are employed for time-sequence modeling. Some models integrate with Internet of Things (IoT) frameworks or federated learning for real-time diagnostics and privacy, often paired with optimization algorithms. However, the adoption of eXplainable AI (XAI) remains limited, despite its importance in building trust in medical diagnostics. Finally, this review outlines future opportunities, focusing on image quality, underexplored deep learning techniques, expanding datasets, and exploring deeper learning representations and model behavior such as recurrent expansion to advance medical imaging diagnostics.

Indexed as

artificial intelligencebrain tumorcancerclassificationdeep learningMRI medical images

Identifiers

PMID39852315
PMCPMC11766058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.